RARRES2 and kidney disorder: Recently, serum chemerin levels have received increasing attention from clinical researchers, including cardiovascular and renal disease-related evaluations (Bonomini and Pandolfi 2016; Zhou, et al. 2019; Szpakowicz, et al. 2021).